Loading...
Revenues Will Fall And Pipeline Risks Will Hinder RNA Upside
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-55.7%7D
-2.9%1Y
-55.7%7D
-2.9%You can edit this narrative until Aug 24 10:55 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 24 10:55 PM. Then, changes will post as Updates.